View source for Document:ICH ICH E2F Guideline 2010

<noinclude>{{#set:
|DocReference=ICH  ICH E2F Guideline  2010
|DocValidityArea=ICH
|DocScopes=G
|DocName=ICH E2F Guideline
|DocVersion=2010
|DocStatus=Current
|DocType=International guideline
|DocLanguage=EN
|DocDescription=DEVELOPMENT SAFETY UPDATE REPORT
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>

{{DocumentBox
|reference=ICH  ICH E2F Guideline  2010
|validity_area=ICH
|scopes=G
|doc_name=ICH E2F Guideline
|version=2010
|status=Current
|doc_type=International guideline
|language=EN
|description=DEVELOPMENT SAFETY UPDATE REPORT
|official_link=https://database.ich.org/sites/default/files/E2F_Guideline.pdf
|restricted=No
|submitted_by=Florian Adragna
|contributors=
}}

<noinclude>
== References ==
{| class="wikitable" style="width:100%;"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:ICH ICH E2F Guideline 2010 1]] || G || 1 || EN || The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including marketed drugs that are under ...
|}
</noinclude>